India’s Hetero Labs Violated GMP Standards, FDA Said

Drug Industry Daily
A A
The FDA flagged a Hetero Labs drugmaking plant near Hyderabad, India for multiple violations of good manufacturing practice standards.

To View This Article:

Login

Subscribe To Drug Industry Daily